NEW YORK, March 15, 2016 -- Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that March 21, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Nobilis Health Corp. (NYSE MKT:HLTH). Nobilis investors are encouraged to contact Scott + Scott at (866) 326-5057 or email [email protected] to discuss their legal rights.
About the Lawsuit
The securities complaint alleges that defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
What you can do
If you purchased shares of Nobilis stock, you may have legal claims against the Company. If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact Geoffrey M. Johnson, Esq. or Joseph Halloran, Esq. by telephone at (866) 326-5057 or by email at [email protected] or [email protected].
About Scott + Scott, Attorneys at Law, LLP
Scott + Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm has offices in New York, London, Connecticut, California and Ohio. Please visit www.scott-scott.com for more information about the firm.
CONTACT: Scott + Scott, Attorneys at Law, LLP Geoffrey M. Johnson, Esq. Joseph Halloran, Esq. (216) 229-6088, toll-free (866) 326-5057 [email protected] [email protected]


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



